Novo Nordisk's R&D facility in Seattle focuses on type 1 diabetes research. Image courtesy of Novo Nordisk.
-
Novo Nordisk's R&D facility in Seattle focuses on type 1 diabetes research. -
The R&D centre in Seattle is supported by Novo Nordisk’s offices in US and... -
Novo Nordisk is headquartered in Denmark and has centres in Denmark, China... -
Novo Nordisk has been involved in diabetes research for the last 88 years.